CLARINEX SYRUP Rx
Generic Name and Formulations:
Desloratadine 0.5mg/mL; bubble-gum flavor.
Merck & Co., Inc.
Indications for CLARINEX SYRUP:
Seasonal allergic rhinitis (for patients ≥2yrs old). Perennial allergic rhinitis, chronic idiopathic urticaria (for patients ≥6 months old).
Adults and Children:
<6 months: not recommended. 6 months–11 months: 1mg (2mL). 1–5yrs: 1.25mg (2.5mL). 6–11yrs: 2.5mg (5mL). ≥12yrs: 5mg (10mL). All: once daily.
ODT: Phenylketonurics. Pregnancy (Cat.C). Nursing mothers: not recommended.
Pharyngitis, dry mouth or throat, myalgia, fatigue, somnolence, dysmenorrhea, headache, nausea, dizziness. Children: fever, diarrhea, upper respiratory infections, irritability, coughing.
Formerly known under the brand name Clarinex ODT.
Tabs (YES); syrup (NO)
Tabs—100, 500; Syrup—4oz, 16oz; ODT—contact supplier
Clinical Pain Advisor Articles
- History of Migraine May Be Associated With Higher Risk for Cochlear Disorders
- Radiofrequency Denervation Efficacious in Treating Thoracic Zygapophyseal Joint Pain
- Symptom Severity, Sensory Sensitivity May Indicate Pain Centralization in Chronic Overlapping Pain Conditions
- Stat Consult: Chronic Low Back Pain
- Opioid Misuse May Help Predict Alcohol Dependence Treatment Outcomes
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- OnabotulinumtoxinA May Be Effective for Chronic Migraine With Medication Overuse
- FDA Outlines Plan for Increasing Nonprescription Drug Availability
- Prescribed Opioids Difficulties Scale Effective for Assessing Concerns of Patients With Chronic Pain
- Hypoesthesia for Touch and Joint Position Linked to Chronic Pain in MS
- New Laws Are Needed to Protect Health Data Shared Online